AAAAAA
Results: 1-25/26
Authors:
Lex, C
Korholz, D
Kohlmuller, B
Bonig, H
Willers, R
Kramm, CM
Gobel, U
Citation: C. Lex et al., Infectious complications in children with acute lymphoblastic leukemia andT-cell lymphoma - a rationale for tailored supportive care, SUPP CARE C, 9(7), 2001, pp. 514-521
Authors:
Creutzig, U
Berthold, F
Boos, J
Fleischhack, G
Gadner, H
Gnekow, A
Graubner, U
Henze, G
Hermann, J
Imbach, P
Jurgens, H
Kabisch, H
Korholz, D
Niemeyer, CM
Reinhardt, D
Reiter, A
Ritter, J
Spaar, HJ
Zimmermann, M
Citation: U. Creutzig et al., Improved treatment results in children with AML: Results of study AML-BFM 93, KLIN PADIAT, 213(4), 2001, pp. 175-185
Authors:
Bonig, H
Silbermann, S
Weller, S
Kirschke, R
Korholz, D
Janssen, G
Gobel, U
Nurnberger, W
Citation: H. Bonig et al., Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF) - results of a prospective randomised monocentre study, BONE MAR TR, 28(3), 2001, pp. 259-264
Authors:
Muller, AE
Domula, M
Stephan, S
Korholz, D
Citation: Ae. Muller et al., Image of the month - Congenital mastocytosis, MONATS KIND, 149(4), 2001, pp. 388-389
Authors:
Engelbrecht, V
Scherer, A
Bruder, M
Korholz, D
Modder, U
Citation: V. Engelbrecht et al., MRI of aseptic osteonecrosis in children with acute lymphoblastic leukemia, ROFO-F RONT, 172(4), 2000, pp. 336-341
Authors:
Rainov, NG
Kramm, CM
Banning, U
Riemann, D
Holzhausen, HJ
Heidecke, V
Burger, KJ
Burkert, W
Korholz, D
Citation: Ng. Rainov et al., Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme, GENE THER, 7(21), 2000, pp. 1853-1858
Authors:
Burdach, S
van Kaick, B
Laws, HJ
Ahrens, S
Haase, R
Korholz, D
Pape, H
Dunst, J
Kahn, T
Willers, R
Engel, B
Dirksen, U
Kramm, C
Nurnberger, W
Heyll, A
Ladenstein, R
Gadner, H
Jurgens, H
Gobel, U
Citation: S. Burdach et al., Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors - An update after long-term follow-up from two centers of the European Intergroup Study EICESS, ANN ONCOL, 11(11), 2000, pp. 1451-1462
Authors:
Stockhorst, U
Spennes-Saleh, S
Korholz, D
Gobel, U
Schneider, ME
Steingruber, HJ
Klosterhalfen, S
Citation: U. Stockhorst et al., Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: Features of a classically conditioned response?, BRAIN BEH, 14(3), 2000, pp. 198-218
Authors:
Creutzig, U
Korholz, D
Niemeyer, CM
Kabisch, K
Graf, N
Reiter, A
Scheel-Walter, H
Bender-Gotze, C
Behnisch, W
Hermann, J
Mann, G
Ritter, J
Zimmermann, M
Citation: U. Creutzig et al., 3 x 14 mg/m(2) Idarubicin during induction: results of a pilot study in children with AML, LEUKEMIA, 14(2), 2000, pp. 340-342
Authors:
Verheyen, J
Bonig, H
Kim, YM
Banning, U
Mauz-Korholz, C
Kramm, C
Korholz, D
Citation: J. Verheyen et al., Regulation of interleukin-2 induced interleukin-5 and interleukin-13 production in human peripheral blood mononuclear cells, SC J IMMUN, 51(1), 2000, pp. 45-53
Authors:
Creutzig, U
Korholz, D
Niemeyer, CM
Kabisch, H
Graf, N
Reiter, A
Scheel-Walter, H
Bender-Gotze, C
Behnisch, W
Hermann, J
Mann, G
Ritter, J
Zimmermann, M
Citation: U. Creutzig et al., Toxicity and effectivity of high-dose idarubicin during AML induction therapy: Results of a pilot study in children, KLIN PADIAT, 212(4), 2000, pp. 163-168
Authors:
Korholz, D
Verheyen, J
Engelbrecht, V
Guillaume, T
Vosberg, H
Gobel, U
Citation: D. Korholz et al., Evaluation of follow-up investigations in children and adolescents with osteosarcoma and Ewing's sarcoma, KLIN PADIAT, 212(4), 2000, pp. 220-223
Authors:
Bonig, H
Laws, HJ
Wundes, A
Verheyen, J
Hannen, M
Kim, YM
Banning, U
Nurnberger, W
Korholz, D
Citation: H. Bonig et al., In vivo cytokine responses to interleukin-2 immunotherapy after autologousstem cell transplantation in children with solid tumors, BONE MAR TR, 26(1), 2000, pp. 91-96
Authors:
Laws, HJ
Nurnberger, W
Korholz, D
Kogler, G
Fischer, J
Niehues, T
Wernet, P
Gobel, U
Citation: Hj. Laws et al., Successful treatment of relapsed CML after cord blood transplantation withdonor leukocyte infusion IL-2 and IFN alpha, BONE MAR TR, 25(2), 2000, pp. 219-222
Authors:
Stockhorst, U
Spennes-Saleh, S
Korholz, D
Gobel, U
Schneider, ME
Steingruber, HJ
Klosterhalfen, S
Citation: U. Stockhorst et al., Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: Features of a classically conditioned response?, ADV DRUG DE, 42(3), 2000, pp. 198-218
Authors:
Bonig, H
Korholz, D
Lex, C
Wolfel, S
Gobel, U
Citation: H. Bonig et al., Monocyte deactivation and its reversal in a patient with chemotherapy-induced leukopenia and severe systemic infection, MED PED ONC, 34(1), 2000, pp. 39-42
Authors:
Irsfeld, H
Korholz, D
Janssen, G
Wahn, V
Schroten, H
Citation: H. Irsfeld et al., Fatal outcome in two girls with Hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy, MED PED ONC, 34(1), 2000, pp. 62-64
Authors:
Niehues, T
Kapaun, P
Harms, DO
Burdach, S
Kramm, C
Korholz, D
Janka-Schaub, G
Gobel, U
Citation: T. Niehues et al., A classification based on T cell selection-related phenotypes identifies asubgroup of childhood T-ALL with favorable outcome in the COALL studies, LEUKEMIA, 13(4), 1999, pp. 614-617
Authors:
Shin, DI
Banning, U
Kim, YM
Verheyen, J
Hannen, M
Bonig, H
Korholz, D
Citation: Di. Shin et al., Interleukin 10 inhibits TNF-alpha production in human monocytes independently of interleukin 12 and interleukin 1 beta, IMMUNOL INV, 28(2-3), 1999, pp. 165-175
Authors:
Schellong, G
Potter, R
Bramswig, J
Wagner, W
Prott, FJ
Dorffel, W
Korholz, D
Mann, G
Rath, B
Reiter, A
Weissbach, G
Riepenhausen, M
Thiemann, M
Schwarze, EW
Citation: G. Schellong et al., High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90, J CL ONCOL, 17(12), 1999, pp. 3736-3744
Authors:
Mauz-Korholz, C
Budde, U
Korholz, D
Gobel, U
Citation: C. Mauz-korholz et al., DDAVP treatment in a child with von Willebrand disease type 2M, EUR J PED, 158, 1999, pp. S174-S176
Authors:
Bonig, H
Banning, U
Hannen, M
Kim, YM
Verheyen, J
Mauz-Korholz, C
Korholz, D
Citation: H. Bonig et al., Transforming growth factor-beta(1) suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes, SC J IMMUN, 50(6), 1999, pp. 612-618
Authors:
Hannen, M
Banning, U
Bonig, H
Kim, YM
Shin, DI
Lorenz, I
Seeger, K
Korholz, D
Citation: M. Hannen et al., Cytokine-mediated regulation of granulocyte colony-stimulating factor production, SC J IMMUN, 50(5), 1999, pp. 461-468
Authors:
Mauz-Korholz, C
Nurnberger, W
Irsfeld, H
Korholz, D
Gobel, U
Citation: C. Mauz-korholz et al., Low rate of severe venous thromboses in children with ALL treatment according to COALL-92 and-97 protocol, KLIN PADIAT, 211(4), 1999, pp. 215-217
Authors:
Laws, HJ
Burdach, S
van Kaick, B
Engel, B
Dirksen, U
Korholz, D
Pape, H
Kahn, T
Merck, H
Schmitz, M
Heyll, A
Dockhorn-Dworniczak, B
Jurgens, H
Gobel, U
Citation: Hj. Laws et al., Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients - A single-center report, STRAH ONKOL, 175(10), 1999, pp. 488-494